Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

AcuCort

0.57 SEK

-16.72 %

Less than 1K followers

ACUC

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-16.72 %
-37.10 %
-5.33 %
-5.80 %
-1.90 %
-26.99 %
-50.40 %
-82.47 %
-77.75 %

AcuCort is a pharmaceutical company. The company develops and commercializes pharmaceuticals based on well-established substances with a focus on user-friendliness and ease of administration. The company's leading product is an oral film for the acute treatment of allergic reactions and other conditions with high medical demand. Products are aimed at patients and caregivers globally. AcuCort was founded in 2006 and is headquartered in Lund, Sweden.

Read more
Market cap
133.16M SEK
Turnover
3.64M SEK
Revenue
690K
EBIT %
-3,839.13 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28/4
2026

Interim report Q1'26

27/5
2026

General meeting '26

All
Press releases
3rd party
ShowingAll content types
Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 17:e mars
Webcast3/17/2026, 7:00 AM

Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 17:e mars

Välkommen att lyssna på Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 17:e mars.

OncopeptidesIntervaccAcuCortOrexoOncoZengeNewbury Pharmaceuticals
Press release3/5/2026, 12:31 PM

Analyst Group: Analyst Group kommenterar AcuCorts deltagande vid partneringkonferensen Bio Europe Spring

AcuCort
Press release3/5/2026, 8:06 AM

AcuCort AB: AcuCort to participate in Bio Europe Spring - focus on international partnerships

AcuCort

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release3/5/2026, 8:06 AM

AcuCort AB: AcuCort deltar på Bio Europe Spring - fokus på internationella partnerskap

AcuCort
Press release2/25/2026, 9:00 AM

Analyst Group: Aktieanalys på AcuCort - Betydande avtal med Glenmark – Tyskland som central marknad

AcuCort
Press release2/23/2026, 9:48 AM

Analyst Group: Analyst Group kommenterar AcuCorts Q4-rapport

AcuCort
Press release2/20/2026, 7:49 AM

Investor Studios: AcuCorts VD Jonas Jönmark presenterar bokslutet live 13.00

AcuCort
Regulatory press release2/20/2026, 7:30 AM

AcuCort AB: AcuCort publicerar bokslutskommuniké för 2025

AcuCort
Press release1/22/2026, 12:35 PM

Investor Studios: AcuCorts VD Jonas Jönmark presenterar Glenmark-avtal live 23 januari 12.00

AcuCort
Press release1/22/2026, 10:55 AM

Analyst Group: Analyst Group kommenterar AcuCorts avtal med Glenmark Pharmaceuticals avseende kommersialisering av Zeqmelit® i sex europeiska länder

AcuCort
Regulatory press release1/22/2026, 7:07 AM

AcuCort AB: AcuCort ingår bindande avtal med Glenmark Pharmaceuticals för Tyskland och ytterligare fem europeiska länder

AcuCort
Regulatory press release1/22/2026, 7:07 AM

AcuCort AB: AcuCort signs commercial agreement with Glenmark Pharmaceuticals for Germany and five additional European countries

AcuCort
Press release12/8/2025, 10:02 AM

Analyst Group: Analyst Group kommenterar AcuCorts hittills största order på Zeqmelit®

AcuCort
Regulatory press release12/8/2025, 7:13 AM

AcuCort AB: AcuCort säkrar ny order på Zeqmelit® - fortsatt tillväxt i Norden

AcuCort
Regulatory press release12/8/2025, 7:13 AM

AcuCort AB: AcuCort Secures New Order for Zeqmelit® - Continued Growth Across the Nordics

AcuCort
Press release12/2/2025, 9:16 AM

Investor Studios: Lär känna din VD: Jonas Jönmark, AcuCort

AcuCort
Regulatory press release11/28/2025, 9:00 AM

AcuCort AB: AcuCort appoints nomination committee

AcuCort
Regulatory press release11/28/2025, 9:00 AM

AcuCort AB: Valberedning i AcuCort utsedd

AcuCort
Press release11/19/2025, 10:39 AM

Analyst Group: Aktieanalys på AcuCort - Intensifierade partnerdialoger

AcuCort
Press release11/17/2025, 9:10 AM

Analyst Group: Analyst Group kommenterar AcuCorts Q3-rapport

AcuCort
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.